| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 01/16/2002 | EP1171580A2 Human homologues of fused gene |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171577A2 Anti-bacterial vaccine compositions |
| 01/16/2002 | EP1171576A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171468A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 01/16/2002 | EP1171464A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0743986B1 Heterologous dimeric proteins produced in heterokaryons |
| 01/16/2002 | EP0721467B1 Use of relaxin as an analgesic and palliative for intractable pain |
| 01/16/2002 | EP0672681B1 Novel antitumor peptide |
| 01/16/2002 | EP0515516B1 Methods for identifying heterofunctional fusion proteins |
| 01/16/2002 | CN1331753A Essential genes from C albicans and method for screening antimycotic substances using said genes |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331700A Generation of antibodies using polynucleotide vaccination in avian species |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331603A Tolerance to xenograft |
| 01/16/2002 | CN1077799C prevention of retinal injury and degeneration by specfic factors |
| 01/15/2002 | US6339183 A vector containing a promoter linked to a heterologous gene that directs expression into the urogenital epithelium of transgenic animals, turning the bladder into a bioreactor; for recovering biologically active molecules from urine |
| 01/15/2002 | US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs |
| 01/15/2002 | US6339061 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338952 Stress proteins and uses therefor |
| 01/15/2002 | US6338950 DNA encoding LST-1 protein and process for recombinant production of LST-1 protein |
| 01/15/2002 | US6338949 A non-genomic recombinant dna; diagnosis and therapy for hairy cell leukemia, viral hepatitis, autoimmune diseases and graft rejection |
| 01/15/2002 | US6338848 Treating multiple sclerosis with immunoglobulins and interleukins |
| 01/15/2002 | US6338846 Genomes with transcription units |
| 01/15/2002 | US6338844 Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 01/15/2002 | CA2089143C Growth factor compositions, preparation and use |
| 01/15/2002 | CA2077347C Cloning vectors and/or expression, their preparation process and their use |
| 01/15/2002 | CA2030951C Process for producing immunostimulant agents |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/10/2002 | WO2002002825A1 Method for the production of proteins and polypeptides using fungal cells, in particular aspergillus vadensis |
| 01/10/2002 | WO2002002793A1 Process for producing glycoprotein |
| 01/10/2002 | WO2002002783A2 Expression vectors |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002640A2 Antibodies to human mcp-1 |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002597A2 Peptide extended glycosylated polypeptides |
| 01/10/2002 | WO2002002591A2 Peptides for use in culture media |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2001055298A3 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins |
| 01/10/2002 | WO2001052668A3 Porphyrin containing lactic acid bacterial cells and use thereof |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004241 Use of beta-catenin in the expansion of stem and progenitor cells |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004232 Nucleotide sequences coding proteins for use in the treatment and prevention of cancer |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004207 Method for diagnosing bone dysbolism |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |